Clinical trial
An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine…
NCT00161044 · University of Maryland, Baltimore, Other · Completed
Key facts
| NCT number | NCT00161044 |
|---|---|
| Title | An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms |
| Official title | An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms |
| Lead sponsor | University of Maryland, Baltimore, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Chronic Schizophrenia |
| Intervention type | Drug |
| Interventions | Galantamine |
| Enrollment | 20 |
| Start date | Sep 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Mar 17, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: